The observation that RhoJ is not mutated in melanoma but yet plays a more important role in the growth of BRAF mutant cells ranging from nevi to tumors indicate that RhoJ is part of a normal signaling pathway that is co-opted to speed tumor development (Fig 5H). The gene discussed is RHOJ; the disease is neoplasm.